Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 5.56% is 611% above its 5-year average of 0.78%, around the middle of its 5-year range (-114.31%–66.98%).
59.00% below its 12-month average of 13.56%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 10.21%.
OPERATING MARGIN
5.56%
OPERATING MARGIN AVG TTM
13.56%
OPERATING MARGIN AVG 3Y
-11.58%
OPERATING MARGIN AVG 5Y
0.78%
OPERATING MARGIN AVG 10Y
32.39%
OPERATING MARGIN AVG 15Y
37.64%
OPERATING MARGIN AVG 20Y
41.58%
CURRENT VS TTM AVG
-59.00%
CURRENT VS 3Y AVG
+148.00%
CURRENT VS 5Y AVG
+611.07%
CURRENT VS 10Y AVG
-82.84%
CURRENT VS 15Y AVG
-85.23%
CURRENT VS 20Y AVG
-86.63%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 384 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Caris Life Sciences, Inc.
Market Cap
$8.59B
Operating Margin
5.56%
TTM Avg
13.56%
3Y Avg
-11.58%
5Y Avg
0.78%
Market Cap
$8.41B
Operating Margin
4.07%
TTM Avg
-1.39%
3Y Avg
-5.39%
5Y Avg
-20.02%
Market Cap
$8.78B
Operating Margin
11.86%
TTM Avg
-8457.60%
3Y Avg
-4268.44%
5Y Avg
-2881.23%
Market Cap
$9.11B
Operating Margin
-24.28%
TTM Avg
-49.63%
3Y Avg
-136.06%
5Y Avg
-90.71%
Market Cap
$9.35B
Operating Margin
3.61%
TTM Avg
7.20%
3Y Avg
11.56%
5Y Avg
12.63%
Market Cap
$7.80B
Operating Margin
-695.44%
TTM Avg
-1799.08%
3Y Avg
-2632.66%
5Y Avg
-1827.24%
Market Cap
$7.61B
Operating Margin
-92.94%
TTM Avg
-50.55%
3Y Avg
-48.57%
5Y Avg
-48.57%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Caris Life Sciences, Inc. (CAI) | $8.59B | 5.56% | 13.56% | -11.58% | 0.78% |
| Oscar Health, Inc. (OSCR)vs › | $8.41B | 4.07% | -1.39% | -5.39% | -20.02% |
| Arrowhead Pharmaceuticals, Inc. (ARWR)vs › | $8.78B | 11.86% | -8457.60% | -4268.44% | -2881.23% |
| Axsome Therapeutics, Inc. (AXSM)vs › | $9.11B | -24.28% | -49.63% | -136.06% | -90.71% |
| Bruker Corporation (BRKRP)vs › | $9.35B | 3.61% | 7.20% | 11.56% | 12.63% |
| Cytokinetics, Incorporated (CYTK)vs › | $7.80B | -695.44% | -1799.08% | -2632.66% | -1827.24% |
| Insulet Corp. (PODD)vs › | $9.39B | 16.89% | 16.20% | 12.06% | 10.90% |
| Hinge Health, Inc. (HNGE)vs › | $7.61B | -92.94% | -50.55% | -48.57% | -48.57% |
| Henry Schein, Inc. (HSIC)vs › | $9.60B | 5.69% | 5.75% | 6.18% | 6.20% |
| Bruker Corporation (BRKR)vs › | $9.72B | 3.61% | 7.20% | 11.56% | 12.63% |
Gross Margin
69.7%
Operating Margin
5.6%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 10.21% |
| 2026-03-31 | 2.44% |
| 2025-12-31 | 30.19% |
| 2025-09-30 | 15.05% |
| 2025-06-30 | 9.92% |
| 2025-03-31 | -47.93% |
| 2024-12-31 | -28.52% |
| 2024-09-30 | -59.87% |
| 2024-06-30 | 66.98% |
| 2024-03-31 | -114.31% |
| 2021-09-30 | 65.90% |
| 2021-06-30 | 59.33% |
| 2021-03-31 | 60.35% |
| 2020-12-31 | 56.07% |
| 2020-09-30 | 44.97% |
| 2020-06-30 | 43.60% |
| 2020-03-31 | 31.98% |
| 2019-12-31 | 28.07% |
| 2019-09-30 | 31.99% |
| 2019-06-30 | 32.61% |
| 2019-03-31 | 31.76% |
| 2018-12-31 | 33.58% |
| 2018-09-30 | 34.87% |
| 2018-06-30 | 35.19% |
| 2018-03-31 | 34.10% |
| 2017-12-31 | 35.73% |
| 2017-09-30 | 33.53% |
| 2017-06-30 | 27.84% |
| 2017-03-31 | 23.10% |
| 2016-12-31 | 22.43% |
| 2016-09-30 | 13.62% |
| 2016-06-30 | 26.17% |
| 2016-03-31 | 28.65% |
| 2015-12-31 | -2.60% |
| 2015-09-30 | 35.07% |
| 2015-06-30 | 39.29% |
| 2015-03-31 | 39.82% |
| 2014-12-31 | 42.94% |
| 2014-09-30 | 43.94% |
| 2014-06-30 | 41.52% |
| 2014-03-31 | 42.02% |
| 2013-12-31 | 46.08% |
| 2013-09-30 | 46.84% |
| 2013-06-30 | 49.28% |
| 2013-03-31 | 48.89% |
| 2012-12-31 | 52.15% |
| 2012-09-30 | 52.84% |
| 2012-06-30 | 50.53% |
| 2012-03-31 | 56.48% |
| 2011-12-31 | 48.35% |
| 2011-09-30 | 53.71% |
| 2011-06-30 | 49.17% |
| 2011-03-31 | 53.95% |
| 2010-12-31 | 57.73% |
| 2010-09-30 | 50.42% |
| 2010-06-30 | 43.36% |
| 2010-03-31 | 31.14% |
| 2009-12-31 | 35.61% |
| 2009-09-30 | 31.62% |
| 2009-06-30 | 33.19% |
| 2009-03-31 | 39.16% |
| 2008-12-31 | 51.19% |
| 2008-09-30 | 51.83% |
| 2008-06-30 | 55.38% |
| 2008-03-31 | 55.27% |
| 2007-12-31 | 62.47% |
| 2007-09-30 | 60.76% |
| 2007-06-30 | 60.62% |
| 2007-03-31 | 62.24% |
| 2006-12-31 | 35.49% |
| 2006-09-30 | 55.41% |
| 2006-06-30 | 49.63% |
| 2006-03-31 | 39.06% |
